The goal of this activity is for learners to be better able to define the latest data in lymphoma from ASH 2024 and assess how these may impact clinical practice.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/ash-2024-highlights-key-lymphoma-data-2024a1000ots
- Start Date: 2024-12-24 06:00:00
- End Date: 2024-12-24 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: ADC Therapeutics America, Inc. - Amount: 21977.0 - Is Kind Support: False Source: Genentech, Inc. - Amount: 70000.0 - Is Kind Support: False Source: Incyte Corporation - Amount: 36628.0 - Is Kind Support: False Source: Novartis Pharmaceuticals Corporation - Amount: 30000.0 - Is Kind Support: False Source: Pfizer Inc. - Amount: 25000.0 - Is Kind Support: False Source: Pharmacyclics LLC - Amount: 50000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest